| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Although tissue inhibitor of metalloproteinases-1 (TIMP-1) is one of the major secretory products of the corpus luteum, the functional significance of this is not clear. In addition to its role as a specific inhibitor of the matrix metalloproteinase enzymes involved in tissue remodelling, it has recently been suggested that TIMP-1 is also a potent stimulator of steroidogenesis in vitro. However, in the ruminant, TIMP-1 expression increases during luteal regression. This study sought to determine (i) the effect of induced luteal regression on ovarian TIMP-1 expression in the primate and (ii) the expression of TIMP-1 in other steroidogenic and non-steroidogenic tissues.
Marmoset ovaries were studied on day 10 of the normal luteal phase and 12 and 24 h after induced luteolysis, with either gonadotrophin-releasing hormone (GnRH) antagonist or prostaglandin F2
analogue. Ovaries from different stages of the normal ovarian cycle were also studied. Expression of TIMP-1 was investigated by isotopic in situ hybridisation. TIMP-1 expression was also examined in a wide range of other marmoset tissues by Northern blotting and in situ hybridisation. TIMP-1 was found to be highly expressed in the marmoset corpus luteum. Luteolysis induced with either prostaglandin F2 or GnRH antagonist was associated with a significant fall in TIMP-1 expression in luteal tissue. TIMP-1 mRNA was also localised to ovarian follicles throughout the ovarian cycle. Expression occurred in the thecal layer of smaller follicles (<1·5 mm) and the granulosal layer of larger pre-ovulatory follicles. In atretic follicles, TIMP-1 was highly expressed at the interface between the thecal and granulosal cells. TIMP-1 was found to be predominantly expressed in steroidogenic tissues, particularly the ovary, adrenal and placenta.
These data support a role for changes in TIMP-1 expression in tissue remodelling in the ovary and are consistent with an additional function of TIMP-1 as a facilitator of steroidogenesis.
Journal of Endocrinology (1996) 151, 203–213
This article has been cited by other articles:
|
|
 |
|
  D. R. Sessions, M. M. Vick, and B. P. Fitzgerald Characterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 and their inhibitors in equine granulosa cells in vivo and in vitro J Anim Sci, December 1, 2009; 87(12): 3955 - 3966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gaytan, M. Gaytan, J. M. Castellano, M. Romero, J. Roa, B. Aparicio, N. Garrido, J. E. Sanchez-Criado, R. P. Millar, A. Pellicer, et al. KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E520 - E531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Duncan, S. van den Driesche, and H. M. Fraser Inhibition of Vascular Endothelial Growth Factor in the Primate Ovary Up-Regulates Hypoxia-Inducible Factor-1{alpha} in the Follicle and Corpus Luteum Endocrinology, July 1, 2008; 149(7): 3313 - 3320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Maybin and W C. Duncan The human corpus luteum: which cells have progesterone receptors? Reproduction, October 1, 2004; 128(4): 423 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Curry Jr and S. E. Wheeler Cellular Localization of Tissue Inhibitors of Metalloproteinases in the Rat Ovary Throughout Pseudopregnancy Biol Reprod, December 1, 2002; 67(6): 1943 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Ricke, G. W. Smith, E. W. McIntush, and M. F. Smith Analysis of Luteal Tissue Inhibitor of Metalloproteinase-1, -2, and -3 During Prostaglandin F2{alpha}-Induced Luteolysis Biol Reprod, May 1, 2002; 66(5): 1387 - 1394. [Abstract] [Full Text]
|
|
|
|
|
|
W. A. Ricke, G. W. Smith, L. P. Reynolds, D. A. Redmer, and M. F. Smith Matrix Metalloproteinase (2, 9, and 14) Expression, Localization, and Activity in Ovine Corpora Lutea Throughout the Estrous Cycle Biol Reprod, April 1, 2002; 66(4): 1083 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Ricke, G. W. Smith, and M. F. Smith Matrix Metalloproteinase Expression and Activity Following Prostaglandin F2{alpha}-Induced Luteolysis Biol Reprod, March 1, 2002; 66(3): 685 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Curry Jr and K. G. Osteen Cyclic Changes in the Matrix Metalloproteinase System in the Ovary and Uterus Biol Reprod, May 1, 2001; 64(5): 1285 - 1296. [Abstract] [Full Text]
|
|
|
|
|
|
F. H. McCaffery, R. Leask, S. C. Riley, and E. E. Telfer Culture of Bovine Preantral Follicles in a Serum-Free System: Markers for Assessment of Growth and Development Biol Reprod, July 1, 2000; 63(1): 267 - 273. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. A. McCracken, E. E. Custer, and J. C. Lamsa Luteolysis: A Neuroendocrine-Mediated Event Physiol Rev, April 1, 1999; 79(2): 263 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Duncan, A. S. McNeilly, and P. J. Illingworth The Effect of Luteal "Rescue" on the Expression and Localization of Matrix Metalloproteinases and Their Tissue Inhibitors in the Human Corpus Luteum J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2470 - 2478. [Abstract] [Full Text]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
